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Abstract: There is a broad consensus that climate change will increase the costs arising 
from diseases such as malaria and diarrhea and, furthermore, that the largest increases will 
be in developing countries. One of the problems is the lack of studies measuring these costs 
systematically and in detail. This paper critically reviews a number of studies about the 
costs of planned adaptation in the health context, and compares current health expenditures 
with MDGs which are felt to be inadequate when considering climate change impacts. The 
analysis  serves  also  as  a  critical  investigation  of  the  methodologies  used  and  aims  at 
identifying research weaknesses and gaps. 
Keywords:  Climate  change;  health  impacts;  adaptation;  cost-effectiveness;  cost-benefit 
analysis. 
 
 
1. Introduction 
 
Climate change is expected to have considerable impacts on human health. The most important 
include  increased  vector-,  water-  and  food-borne  diseases;  injuries  and  deaths  caused  by  extreme 
hydro-geological events; heat-related diseases and deaths caused by heat waves (thermal stresses); and 
negative impacts on malnutrition [1,2]. These negative consequences might be compensated by some 
beneficial effects, such as fewer deaths from cold weather in temperate regions, but the overall impact 
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is  expected  to  be  negative.  Evidence  suggests  that  developing  countries,  including  those  of  sub-
Saharan Africa are expected to suffer major health impacts from climate change. 
In order to  reduce these negative health impacts,  various programs  or measures,  known in  the 
climate literature as adaptation measures, are being put in place or are being planned. Adaptation is 
defined by IPCC (Intergovernmental Panel on Climate Change) as the “adjustment in natural or human 
systems in response to actual or expected climatic stimuli or their effects, which moderates harm or 
exploits beneficial opportunities” [1]. The issue of adaptation to the health impacts of climate change 
is receiving considerable attention in scientific research and policy debate, particularly after this last 
report of the IPCC, and is emerging as a policy priority. It is also recognized that adaptation should be 
more  and  more  integrated  into  development  policies  and  decision-making  processes.  This  is 
particularly important for developing countries, where the potential to adapt is constrained by a lack of 
resources, low health expenditure, weak health care systems and poor health status of the populations. 
In this context, international assistance for adaptation is foreseen in the least developed countries and 
small island developing states. Sources of funding include the Global Environment Facility (GEF) 
under the UNFCCC (e.g. Least Developed Countries Fund and Special Climate Change Fund) and the 
Adaptation  Fund  (AF)  under  the  Kyoto  Protocol,  aiming  to  support  adaptation  for  food  security, 
disaster prevention, water accessibility and disease control.  
For  informed  decision-making,  national  governments  need  therefore  to  know  what  financial 
resources are needed for adaptation, what is the financial gap in funding, what damages could be 
avoided through adaptation, and what is the cost-effectiveness of the proposed programs. This would 
allow them to set priorities and to choose the most appropriate combination of measures to reduce the 
negative health impacts. 
This paper critically reviews a number of studies on the costs of health interventions. It analyses the 
methodological approaches used and identifies critical gaps and research priorities in this area. The 
goals are three-fold. First, we wish to explore the economic impact of climate change in developing 
countries in terms of planned adaptation costs, based on the empirical evidence from the existing 
literature. Quantification of the health costs of adaptation requires an extensive analysis of long-term 
data including the increase in the number of cases and deaths caused by climate change, as well as 
economic variables such as unit costs of specific health measures. Such an analysis is more complex in 
developing countries, due to the lack of consistent long-term datasets. Given these difficulties and the 
limited number of studies in the context of health adaptation, the analysis is completed by selecting a 
number of relevant studies coming from the public health literature for climate-related disease control 
programs. Second, we use the estimated total costs resulting from the literature to perform a simple 
cost-effectiveness analysis of different health interventions for different diseases, in order to identify 
the alternatives with the lowest cost to achieve the desired result. Preventive and reactive measures for 
different health endpoints are compared, the first aiming at avoiding deaths or episodes of illness, 
while the second are intended to treat the disease when already occurred and minimize the damage. 
Third, this analysis serves also as a critical investigation of the methodologies used for cost assessment 
with the purpose of identifying the research gaps and the conditions that need to be satisfied to assure 
reliable estimates.  
Section 2 presents a brief overview of the main health impacts caused by climate change with a 
specific focus on developing countries. Section 3 presents a classification of adaptation measures, Int. J. Environ. Res. Public Health 2009, 6                 
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identifies  the  main  cost  categories  and  reports  on  the  methodological  approach  used  for  cost 
assessment. The methodological issues that arise in judging whether a measure is justified from an 
economic  point  of  view  are  discussed  in  Section  4,  reporting  on  two  main  approaches,  cost 
effectiveness analysis and cost-benefit analysis. Section 5 details the existing studies on the costs of 
health interventions to reduce climate-related diseases, comparing results among macro-geographical 
regions. In Section 6 different health interventions are discussed in term of their cost-effectiveness. 
Finally Section 7 discusses the existing research gaps, the main methodological issues in the cost 
assessment and how to improve knowledge. 
2. Health Impacts of Climate Change  
Climate change will have a wide range of implications to human health. These include thermal-
related morbidity and mortality due to extreme temperatures, effects associated with air pollution, 
impacts of extreme weather events, malnutrition, water-borne (e.g. diarrhea, cholera, typhoid), food-
borne (e.g. Salmonella) and vector-borne diseases (e.g. malaria, dengue).  
The increase in  the frequency and intensity of  extreme temperatures  will  have both  direct  and 
indirect  effects  on  health.  Direct  effects  include  thermal  stresses  (cardio-vascular  and  respiratory 
diseases, heat exhaustion, heat cramps and dehydration), while indirect effects are related to the impact 
of heat extremes on urban air pollution and humidity (which can aggravate pre-existing morbidity).  
The risk of heat-related morbidity and mortality would increase mainly in the elderly, children, 
those  with  pre-existing  cardio-vascular  and  respiratory  diseases,  and  among  the  urban  poor.  The 
greatest impact is expected for mid- to high-latitude cities, especially in poor countries, characterized 
by poorly adapted buildings and without air conditioning. Lack of datasets and long-term statistics in 
developing  countries  makes  it difficult  to  provide quantitative estimates  of  health effects  in  these 
countries. Nevertheless some studies exist which project large impacts in the temperate and tropical 
regions in Asia and India [2-4]. 
The negative impact of heat waves might be partially compensated by a decrease in cold-related 
deaths  during  the  winter  season.  According  to  some  studies,  the  decrease  in  winter  mortality  in 
temperate regions might be greater than the increase in heat-related mortality expected in summer 
[5,6]. These results are still under debate, as the projected mortality due to cold-related stresses might 
be overestimated if the effect of influenza is not considered [7]. Further research is needed in this 
context to understand how the results vary under different climate and socio-economic scenarios. The 
health benefits are nevertheless expected only in temperate regions, while globally they will be greatly 
compensated  by  the  increased  impact  of  other  diseases,  specifically  infectious  diseases  and 
malnutrition in developing countries. 
Extreme temperatures may also increase the exposure to urban air pollution, with the potential to 
aggravate pre-existing respiratory and cardio-vascular diseases. In the recent years, extreme weather 
events, such as floods and landslides, storms, cyclones and droughts, have caused considerable damage 
and loss of life in China, Venezuela, Bangladesh and Mozambique. Direct impacts of extreme weather 
events  include  increased  incidence  of  deaths,  physical  injuries  and  psychological  stresses,  while 
indirect  impacts  are  related  to  increased  risk  of  exposure  to  water-borne  diseases  due  to  water 
contamination, and impacts on malnutrition due to loss in agricultural production. Unsafe water and 
sanitation  conditions  and  decrease  water  accessibility  would  further  increase  the  transmission  of Int. J. Environ. Res. Public Health 2009, 6                 
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infectious diseases. It is estimated that by 2050, one billion people in Asia could have limited access to 
drinking water [8]. 
Other indirect impacts of changes in weather patterns include variation in the geographical and 
seasonal distribution of vector-borne diseases (malaria, dengue, leishmaniasis, lyme disease, tick-borne 
encephalitis), in some cases by expanding transmission to higher altitudes and latitudes. There is, 
however, considerable uncertainty as to the magnitude of the impacts. Some mathematical models 
project a net increase in the amount of population exposed to malaria and dengue transmission as a 
result of climate change [9], while other models suggest only little change in malaria distributions [2]. 
 
Table 1. Health Impacts of Climate Change: Classification. 
 
 
  Health impacts 
Climate impacts  Direct  Indirect 
Temperature extremes (heat 
or cold waves). 
Heat- and cold- related stresses 
 
-  Respiratory and cardio-vascular 
diseases due to the combined 
effect of exposure to high 
temperature and air pollutants 
Extreme weather events 
Floods,  landslides,  storms, 
cyclones 
Deaths and injuries  - Water-borne diseases caused by 
water contamination and poor 
sanitation conditions 
- Psychological morbidity 
Droughts  −  - Malnutrition and under-nutrition, 
due to loss of agricultural 
production 
- Water-borne diseases caused by 
decreased water access and 
malnutrition 
- Vector-borne diseases due to 
changes in vector transmission 
and stagnation/contamination of 
small rivers and drainage canals 
- Respiratory diseases due to 
increased air-borne particulate 
matter and increased 
vulnerability caused by 
malnutrition and other diseases 
Increased temperature  −  - Vector-borne diseases due to 
higher risk of transmission and 
changes in the geographical and 
seasonal distribution 
- Food-borne diseases due to food 
contamination  Int. J. Environ. Res. Public Health 2009, 6                 
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Finally,  higher  temperatures  can  lead  to  increased  exposure  to  food-borne  diseases  due  to 
contamination of food, which can cause various gastrointestinal diseases. Notwithstanding the existing 
scientific uncertainties, most researchers project that in the next decades these health impacts are likely 
to increase considerably in developing countries, which are more vulnerable to climate change impacts 
and less capable to adapt to such changes, having poor health care systems, poor health status, and few 
financial, social and technological resources to adapt. Hence climate change is threatening the capacity 
of these countries to attain the United Nations Millennium Development Goals by 2015 (UN 2015). It 
is therefore crucial to understand how climate change is likely to impact development priorities in poor 
countries, and to respond with appropriate and cost-effective measures for adaptation.  
Table 1 reports major direct and indirect effects of climate change on human health, while Table 2 
indicates the main health impacts projected for developed and developing countries together with some 
indication of their adaptive capacity. 
 
Table 2. Health Impacts of Climate Change in Developed and Developing Countries. 
Region  Health Impacts  Adaptive Capacity 
Africa  -  Changing in spatial and temporal distribution of 
malaria, dengue, diarrhea, cholera, meningitis, etc. 
-  Increased deaths and injuries due to extreme weather 
events in new areas 
-  Malnutrition 
Low adaptive capacity due to lack of 
financial and technological resources, 
low GDP per capita, poverty, limited 
infrastructure, weak primary health 
care, high infant mortality, low 
education levels, limited access to 
capital, armed conflicts. 
Asia  -  Thermal stresses due to heat waves in East Asia 
-  Air pollution related diseases 
-  Transmission of malaria to new areas 
-  Increased morbidity and mortality due to diarrhea in 
South and Southeast Asia and cholera in South Asia 
-  Increased deaths and injuries due to flooding and 
extreme events in East Asia, Southeast and South 
Asia 
-  Malnutrition  
Adaptive capacity varies among 
countries and is often constrained due 
to poor financial and technological 
resources, income inequalities and 
weak health care system. 
 
Latin 
America 
-  Thermal stresses due to heat waves in big cities  
-  Transmission of vector-borne diseases to new areas, 
including malaria 
-  Increased deaths and injuries due to tropical cyclones 
in the Caribbean basin 
-  Rodent-borne infections after flooding and droughts 
Limited adaptive capacity due to high 
infant  mortality,  income  inequalities, 
weak health care system. 
Small 
Island 
developing 
states 
-  Thermal stresses due to heat waves 
-  Transmission of vector-borne diseases to new areas 
and increased morbidity and mortality due to diarrhea  
-  Increased deaths and injuries due to tropical cyclones  
Low  adaptive  capacity,  due  to  poor 
resources, weak health care system and 
high frequency of natural hazards Int. J. Environ. Res. Public Health 2009, 6                 
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Europe  -  Thermal stresses due to heat waves 
-  Air pollution related diseases 
-  Increased deaths and injuries due to extreme events 
and flooding 
-  Expected increase in lyme disease and tick-borne 
encephalitis in temperate regions 
-  Expected increase in leishmaniasis in Mediterranean 
countries 
Adaptive capacity higher than in 
developing countries. 
Existing public health resources will 
allow to put in place curative and 
preventive measures to face at least part 
of the health impacts. 
 
North 
America 
-  Thermal stresses due to heat waves, mainly in Nord-
east and Mid-west 
-  Injuries and mortality due to storms, floods, 
hurricanes, tornadoes and ice storms 
-  Increased vector and water-borne diseases 
Adaptive capacity higher than in 
developing countries. 
Existing public health resources will 
allow to put in place curative and 
preventive measures to face at least part 
of the health impacts. 
Australia 
and New 
Zealand 
-  Thermal stresses due to heat waves 
-  Air pollution related diseases 
-  Increased deaths and injuries due to tropical cyclones 
and floods 
-  Increased transmission of vector-borne diseases 
(dengue) 
Adaptive capacity higher than in 
developing countries. 
Existing public health resources will 
allow to put in place curative and 
preventive measures to face at least part 
of the health impacts. 
Source: adapted from UNFCCC 2007 [10]. 
 
3. Measuring the Health Cost of Adaptation Policies: Methodological Approach 
 
3.1. Health Adaptation Policies and Categorization of Costs 
 
In order to cope with the adverse health effects of climate change, adaptation measures, plans and 
programs are put in place. Adaptation is defined in terms of “policies, practices, and projects with the 
effect of moderating damages and/or realizing opportunities associated with climate change” [11]. 
Adaptation  can  be  classified  according  to  different  criteria  or  aspects  [11].  The  most  important 
classification is between autonomous (or private) and planned (or public) adaptation. IPCC defines the 
first as “adaptation that does not constitute a conscious response to climate stimuli but is triggered by 
ecological changes in natural systems and by market or welfare changes in human systems”, while the 
second is “adaptation that is the result of a deliberate policy decision based on an awareness that 
conditions have changed or are about to change and that action is required to return to, maintain, or 
achieve a desired state” [12]. 
Another  important  classification  distinguishes  between  anticipatory  (or  proactive)  or  reactive 
adaptation. The first implies preventive actions which take place before the impact occurs in order to 
avoid of reduce the risk of disease and death. This type of adaptation involves long-term decision 
making  and reduces  long-term impacts,  risk and vulnerability  caused by  climate change.  For this 
reason, anticipatory adaptation is more effective and involves generally planned interventions. On the 
other side, reactive adaptation provides an immediate response to climate change. The actions take 
place after the impact with detection and subsequent treatment of the disease. In the public health 
sector, adaption actions are usually classified into three categories according to the timing: primary, 
secondary and tertiary [2,13]. Primary prevention regards health interventions put in place before the Int. J. Environ. Res. Public Health 2009, 6                 
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damage occurs in order to avoid it by reducing exposure (e.g. warning systems, water and sanitation 
programs, distribution of impregnated bed nets, flood protection structures,  etc.). When the health 
interventions are implemented after the impact has occurred but before the occurrence of the disease, it 
is  termed  as  secondary  prevention.  These  include  measures  such  as  monitoring  and  surveillance 
programs allowing an early detection of the disease (e.g. medical tests), or strengthening the public 
health care. Finally tertiary measures do not attempt to prevent, but to minimize the health impacts 
already occurred, e.g. through curative treatments. 
 
Table 3. Health Adaptation Measures to Climate Change. 
Adapta-
tion 
measures 
Health impacts 
Thermal 
stresses 
Extreme weather 
events 
Vector-borne 
diseases 
Water-borne 
diseases 
Food-borne 
diseases 
L
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a
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e
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a
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y
 
A
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t
i
c
i
p
a
t
o
r
y
 
 
- Building 
guidelines 
 
- Building guidelines 
- Economic incentives 
for building 
- Urban planning 
regulation 
- Forced migration 
  - Watershed 
protection laws 
- Water quality and 
water supply 
regulation 
 
- Food sanitation 
and hygiene 
regulation 
T
e
c
h
n
i
c
a
l
 
A
n
t
i
c
i
p
a
t
o
r
y
 
- Urban planning 
(green islands, 
fountains, green 
roofs) 
- Thermal building 
insulation and air 
conditioning 
- Urban planning 
(flood-resistant) 
- Flood protection 
elevation 
- Flood protection 
structures (dams, 
dykes, walls and 
raised banks, pump 
stations) 
- Reforestation 
 
- Vector control 
- Vaccination, 
impregnated bed 
nets 
- Surveillance, 
prevention and 
control programs 
- Epidemic 
forecasting 
 
 
 
- Water treatment 
and distribution 
- Monitoring water 
sources 
- Regulated piped 
water in houses 
- Improved 
sanitation (latrines) 
- Household sewer 
connection  
- Surveillance, 
prevention and 
control programs 
- Refrigeration 
- Chlorination of 
drinking water 
- Pasteurization of 
milk 
- sanitary slaughter 
and processing o 
meat, poultry and 
seafood 
 
R
e
a
c
t
i
v
e
 
 
- Financial and 
domiciliary 
assistance services, 
“telecare” systems, 
accompaniment 
and transport to 
emergency medical 
services 
- Emergency plans 
(hospital and 
primary care) 
- Pre-disaster 
recovery plans 
- First aid and 
emergency plans 
- Temporary 
evacuation 
 
- Hospital and 
primary care 
- Outreach doctors 
 
- Hospital and 
primary care 
- Outreach doctors 
 
 
 
- Food-borne 
disease surveillance 
- Hospital and 
primary care 
- Outreach doctors 
E
d
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a
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i
s
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y
 
 
A
n
t
i
c
i
p
a
t
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- Heat watch 
warning systems 
- Educational 
campaign 
- Real-time 
forecasting 
- Early warning 
systems 
- Educational 
campaign 
- Education 
campaign 
- Health 
educational 
campaigns 
- Boil water alerts 
- Food safety 
education Int. J. Environ. Res. Public Health 2009, 6                 
 
766 
Table 3. Cont. 
C
u
l
t
u
r
a
l
 
a
n
d
 
b
e
h
a
v
i
o
u
r
 
A
n
t
i
c
i
p
a
t
o
r
y
 
Clothing, drinking, 
visiting places with 
air conditioning 
and green areas 
- Use of storm 
shelters 
 
 
- Water storage 
practices 
- Washing hands 
and hygiene 
- Use of pit latrines 
- Avoid high risky 
food (such as runny 
eggs and raw 
shellfish) 
- Separating 
cooked and raw 
food 
- Wash hands, 
cutting boards and 
contaminated 
surfaces  
Sources: adapted from [12] and [15]. 
 
Other criteria distinguish between short term and long term adaptation, localized and widespread 
adaptation [11]. Finally, adaptation measures can be grouped into four main categories, according to 
their function and form: legislative/regulatory, technical, advisory/educational, cultural/behavioral.  
Legislative measures consist of laws, guidelines and regulations put in place by the parliament and 
government to prevent negative impacts of climate change. Technical measures can be anticipatory or 
reactive,  they  can  be  implemented  by  various  government  departments  depending  on  the  type  of 
measure (e.g. vaccination programs issued by the public health care sector), by the municipality (e.g. 
green islands in the city centre) or by the industrial sector (e.g. thermal building insulation). Education 
measures can be implemented by the central government with the cooperation of various departments 
(e.g. public health). Finally, the behavioral measures are put in place by individuals and they are 
defined as autonomous adaptation. 
Examples  of  possible  health  adaptation  actions  are  reported  in  Table  3.  Some  of  the  listed 
interventions are supported and put in place by the public health sector (like health education activities, 
or disease surveillance and monitoring). Others, like water treatment and distribution or construction 
of flood protection structures, are put in place outside the health sector, involving other government 
departments. Finally, adaptation may include structural and non-structural interventions, where the 
former,  as  the  name  suggests,  implies  the  creation  of  infrastructures,  hardware,  house  alteration, 
planning or setting of construction standards (e.g. flood protection structures, water treatment and 
distribution).  Non-structural  measures,  instead,  include  all  other  interventions  put  in  place  for 
treatment or prevention of the disease (e.g. curative treatments, distribution of impregnated bed nets, 
vaccination, and educational campaigns). 
The cost of health adaptation programs includes the cost of building, operating and maintaining 
health provision service structures, setting up and running emergency response systems, etc. We can 
distinguish different categories of costs, according to the type of adaptation [14]. The first category 
includes  the  direct  costs  related  to  the  implementation  of  a  specific  measure  (costs  of  medicines 
provision and distribution, preventive therapies, etc.). The second category involves institutional costs 
incurred to improve the adaptive capacity of a system. These include actions for strengthening the 
health care system, infrastructure costs, training activities, communication, monitoring, surveillance 
and evaluation services, health information systems and population surveys. Finally, the last category 
includes the transition costs associated with the reallocation of the resources in the society during the Int. J. Environ. Res. Public Health 2009, 6                 
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adaptation  process  (e.g.  shifts  of  financial  resources  to  other  markets).  Transition  costs  are  often 
excluded from the analysis, due to the difficult estimation process. 
From an economic point of view, we should estimate the social costs of adaptation programs. These 
include  external  costs  incurred  by  the  society  (opportunity  costs),  besides  the  private  costs  of 
production. The studies analyzed in this paper focus on the first two categories of costs mentioned 
above, namely direct and institutional costs, excluding transition and opportunity costs. 
The costs of health adaptation are estimated using market-based data and information in order to 
perform  a  cost  assessment  based  on  unit  values  multiplied  by  the  target  population  living  in  the 
vulnerable areas and by the incidence of diseases. Health adaptation costs include treatment costs of 
additional cases (reactive adaptation) and costs for preventive measures to reduce the incidence of 
disease (proactive adaptation). The cost of health adaptation will depend on the health outcome, the 
intervention type (e.g. treatment or prevention), the expected reduction in the incidence of mortality 
and morbidity and finally on the geographical region where the impact is expected.  
 
4. Use of Evaluation Tools for Policy-Making in Health Contexts 
 
As important as estimating the costs of adaptation programs for health protection, is to have some 
way of judging whether these costs are reasonable and whether the program  is  justified.  For this 
purpose  economists  use  two  tools:  Cost-Benefit  Analysis  (CBA)  and  Cost-Effectiveness  Analysis 
(CEA). The main difference between CBA and CEA is that in CBA both the costs and benefits of a 
proposed program are estimated in monetary terms, and then compared with the costs and benefits of 
alternative programs, in order to identify the program with the highest net benefits. By contrast, CEA 
estimates only the costs of attaining certain health goals, which are measured in physical units (number 
of lives saved, number of cases of illness avoided, and quality adjusted life years - QALY). 
 
4.1. Cost Effectiveness Analysis 
 
Cost-effectiveness analysis (CEA) is a technique used to identify the least cost intervention to reach 
a  desired  result.  It  enables  us  to  define  priorities  among  different  alternative  interventions  by 
identifying the least cost option able to reach the underlying objectives. CEA is sometimes used as a 
second-best option when a full-blown CBA would be desirable, but many benefits cannot easily be 
monetized [15].  
The  cost-effectiveness  ratio  of  a  program  is  computed  by  dividing  the  annualized  costs  of  the 
program by the physical benefits, measured in terms of lives saved (or life years saved), and cases of 
illness avoided. Results are expressed as unit costs, in terms of costs to be supported to save one life 
(or one year life) and to avoid one episode of illness. If all else is the same, the program deemed more 
cost-effective would be the one with the lowest cost per life saved or avoided case. For example a 
government might decide that any project where the cost per life year saved is in excess of €1,000 
cannot  be  funded.  It  could  arrive  at  this  conclusion,  given  information  on  the  range  of  possible 
interventions, the cost per life year associated with them and the budgetary resources available. Each 
project then would have to report a cost per life year saved and a necessary condition for adopting it 
would be that this cost is less than €1,000. This approach is attractive because: (a) it is generally 
feasible (although not always easy) to calculate the cost per life year saved or case avoided from health Int. J. Environ. Res. Public Health 2009, 6                 
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related interventions and (b) the criteria are simple and transparent. Traditionally, CEA has been used 
widely in medical decision-making and in public health although in practice the selection of health 
interventions does not rely exclusively on this criterion [16].  
Estimation of the costs of a program within a CEA is similar to that in a CBA. The advantage of the 
first is that the benefits are computed in physical terms and not in monetary terms as in a CBA, which 
results in a less complex calculation. Analysts engaging in a CEA, however, still have to deal with 
complex issues such as the choice of the discount rate when the costs of the program are incurred over 
several periods. Further problems arise when a program impacts on more than one indicator (e.g. it 
results in savings in life years as well as a reduction in the experience of unpleasant symptoms). In 
such cases other criteria have to be used or one has to be chosen at the expense of the other This is 
particularly relevant as a program could reduce both mortality and morbidity impacts, and in this case 
the use of one indicator (cost per case avoided) instead of the other (cost per life saved) could have 
misleading results if the two measures differ widely.
 In these cases another physical indicator known 
as the Quality Adjusted Life Year (QALY) is routinely used in medical decision-making and public 
health. This measure is based on the individual preferences over quality of life and longevity, which 
are assumed to depend on the health consequences (it is assumed that a year of healthy life expectancy 
is worth 1, while a year of unhealthy file expectancy is worth less than 1, being this value lower the 
worse  the  quality  of  life).  This  indicator  has  the  advantage  of  incorporating  both  mortality  and 
morbidity effects, instead of favoring one of the two. The main problem with this approach is that 
older individuals would have fewer QALYs than younger individuals, which would lead to higher cost 
per case avoided or per life saved for the elderly. Furthermore this approach does not account for 
individual risk perception. For these reasons, in our computations we use the indicator cost per case 
and/or death avoided. 
In the context of climate change CEA is a useful tool to provide a measure of the costs of a program 
in terms that are comparable across programs. Studies on the costs of adaptation programs are indeed 
difficult to compare in a way that provides some guidance on whether they are justifiable or not. 
Although imperfect, measures such as the cost per case avoided or cost per life year saved are at least 
feasible and the numbers obtained useful for policy purposes.  
 
4.2. Cost Benefit Analysis 
 
This  technique  has  been  used  to  analyze  many  public  policies,  including  transportation,  urban 
regeneration, agriculture, public health, education, and the environment. It is also used for valuing for 
adaptation to climate change impacts. By monetizing the benefits of a program, CBA makes it possible 
to evaluate many different types of government programs and to compare them with the costs of the 
programs.  When  different  programs  are  examined,  economists  suggest  choosing  the  one  with  the 
largest net benefits (equal to total benefits minus total costs of the policy). Note that, unlike CEA, cost-
benefit analysis also allows one to determine the socially optimal size of the program, i.e., the one that 
maximizes net benefits.  
In order to determine the net effect of a proposed program, we must first identify who will gain 
(beneficiaries) and who will lose from its implementation, and then estimate the gains or losses for 
each of the partners. In spite of that equity considerations are not sufficiently reflected in CBAs (the 
argument that projects or policies with the best benefit-cost-ratio are socially desirable rests on the Int. J. Environ. Res. Public Health 2009, 6                 
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assumptions that the gainers can – in principle – compensate the losers of a project/policy and still be 
better off. Since such compensation is not generally paid, most projects or policies have distributional 
implications that need to be taken into account). CBA is complicated further by the fact that, while it is 
quite easy to identify the costs, it is more difficult to estimate the benefits, as these are generally non-
market goods, for which no market prices exist.  
Another problem with  CBA is  that it must  compare costs and benefits  that are experienced at 
different times in a single measure. The choice of the rate at which future costs and benefits should be 
discounted is particularly relevant for climate projects because costs of adaptation measures will be 
incurred in the near future while the benefits will be spread over a much longer time period. The 
debate on discounting for climate change is not resolved but many economists argue that very long 
term impacts of the kind associated with climate change require very low discount rates – of the order 
of one percent or less. In practice normal public sector projects involve discount rates of around 5-6 
percent [18]. 
One other feature of the use of CBA to evaluate health adaptation programs is worth mentioning. 
This is the problem of valuing benefits that take the form of reductions in mortality – implying savings 
in life years, which in turn requires a value to be attached to a life year or a life saved. In the past this 
has  produced  serious  debate  and  disagreement.  Methods  have  been  developed  for  making  such 
estimates, but the studies are mainly from developed countries. In the context of climate change the 
use of different values for a life year according to the country in which the person lives has raised 
serious  problems  (this  issue  created  a  political  crisis  at  the  time  of  the  2
nd  IPCC  Report  when  a 
recommendation to take a lower value of life in developing countries compared to industrialized was 
strongly objected by representatives from developing countries). Studies in the climate change field 
have wrestled with this problem and resolved it with broadly two uneasy compromises. Some have 
taken different values for different countries, more or less in proportion to real per capita GDP [17]. 
Others have applied the same value to all lives saved, irrespective of the country in which the person is 
resident [18]. Neither is really satisfactory and a number of scientists working in this field feel that this 
issue is itself enough to avoid using CBA in the context of climate change (however some targeted use 
of CBA may be appropriate and useful when for example an intervention has multiple benefits and the 
monetary estimation of the non-health benefits is strong). Given the difficulties in estimating health 
benefits in monetary terms, we have used the cost per case avoided and cost per life saved to compare 
effectiveness among different health programs. 
 
5.  Assessing  the  Costs  of  Health  Interventions  in  Developing  Countries:  Empirical  Evidence 
from the Literature 
 
The analysis reviews a number of valuable studies about the costs of health interventions (planned 
actions) to reduce the disease incidence and related mortality, with a specific focus on developing 
countries, expected to face most of the health impacts of climate change. The studies selected focus on 
similar targets in terms of health impacts reduction, which allows comparison among interventions 
types and countries. The health outcomes considered in the analysis are vector-borne and water-borne 
diseases, malnutrition, pneumonia and newborn causes of death in children. It must be recognized that 
quantification of costs is much more difficult in developing countries, due to the lack of data and long-Int. J. Environ. Res. Public Health 2009, 6                 
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term analysis, high variation of data among countries, inefficiencies in disease detection and reporting. 
Nevertheless we have selected some relevant studies in order to analyze the methodology and to draw 
some quantitative estimates of the cost of health adaptation. 
There are two main groups of studies considered in this analysis. The first relate to health care costs 
associated with the additional health impacts arising as a result of climate change. These costs include 
disease  treatment  measures  (reactive  adaptation)  as  well  as  preventive  measures  to  reduce  the 
incidence of climate related diseases (anticipatory adaptation). Despite the important role of adaptation 
in reducing the health costs of climate change (known as the „costs of inaction‟), there is very little 
information available from the literature on the costs of health adaptation in different climate change 
scenarios. For this reason we have reported on a second group of studies focusing on the costs of 
health interventions programmed to achieve a reduction in the burden of climate-related diseases, in 
accordance  with  internationally  agreed  objectives  and  targets,  like  the  MDGs.  These  costs  are 
estimated outside the climate change context, but they focus on climate-related diseases (e.g. malaria, 
diarrhea, pneumonia). As the types of measures used for disease treatment and  prevention are, in 
principle, the same in both contexts, the second group of studies can be reasonably used to provide 
some indications of how much adaptation measures would cost.  
The above mentioned studies focus on planned interventions only as they aim at identifying 
the  financial  resources  needed  by  the  government  to  address  the  increased  impact  of 
climate-sensitive  diseases.  Autonomous  adaptation,  which  includes  costs  supported  by 
households,  is  not  taken  into  account.  The  figures  discussed  in  this  paper  represent 
therefore a lower-bound estimate of the total costs of health adaptation supported by the 
society  as  a  whole.  Household  costs  include  direct  expenditures  for  health  for  both 
prevention and treatment (medical care costs, medicines) and indirect costs such as loss of 
earnings due to absence from work, inability to perform usual activities, need to care for 
children,  time  spent  travelling  and,  in  case  of  premature  death,  the  discounted  future 
lifetime earnings or the value of a statistical life. These studies are not included in the 
present review as the methodological approaches used for estimating these impacts rely on 
different  theoretical  backgrounds,  raising  specific research issues.  Methods  used in  this 
context include cost of illness, compensating wage studies and contingent valuation. 
5.1. Costs of Health Adaptation Due to Climate Change Impacts 
The methodological approach for estimating health adaptation costs requires to estimate the disease 
incidence due to climate change, to project future population under different scenarios, and to estimate 
the number of people at risk in the future (multiplying future population with the incidence ratio). The 
costs of adaptation are assessed by multiplying the number of people at risk in the future with the cost 
per capita of health interventions. 
Perhaps the most important study in this category is that of Ebi [19] who estimated the costs of 
specific interventions for treatment of additional cases of malaria, diarrhoea and malnutrition expected 
to  occur  between  year  2000  and  2030,  due  to  climate  change.  These  were  estimated  under  three 
exposure scenarios related to climate change: unmitigated emission trends, stabilization at 750 ppm 
CO2 equivalent by 2210 and stabilization at 550 ppm CO2 equivalent by 2170. Estimates are provided 
separately  for  Africa,  North  and  South  America,  South-East  Asia,  Europe,  Eastern  Mediterranean 
countries and Western Pacific countries. The estimated figures do not include the full range of costs 
[20];  for  example  infrastructure,  equipment  and  health  care  personnel  costs,  training  costs  and Int. J. Environ. Res. Public Health 2009, 6                 
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maintenance costs are excluded from the analysis. For diarrhoea, the costs included in the analysis are 
those related to immunization programs and improvement in water supply and sanitation. As regards 
malaria,  the  estimated  measures  include  provision  of  impregnated  bed  nets,  indoor  spraying,  and 
preventive treatment in pregnancy, besides the specific required therapies. Finally for malnutrition, the 
approach used is very conservative, as only the costs of nutritional programs and monitoring have been 
included. For all their gaps, however, these estimates are probably closest available to the desired costs 
of adaptation.  
Total costs under various categories for the year 2030 are summarized in Table 4. The figures show 
malaria as the most significant, representing just under over half the total costs, followed closely by 
diarrhea,  which  accounts  for  just  under  half.  Malnutrition  related  illnesses  are  only  a  minor 
component, making up just one percent of the total, but we should consider that this is a lower bound 
estimate and that most of the impacts have not been calculated. 
For the sake of comparison among different countries, additional annual costs have been calculated 
for major geographical macro-regions in developing and developed countries. Detailed estimates for 
these macro-regions are reported in Table 5 below only for diarrhoea and malaria, which account for 
the majority of total costs. As expected, developed countries account only for a minor share of total 
costs (around 3-4% for diarrhoeal diseases, and 0.008% for malaria), while developing countries will 
bear almost all the projected additional costs. 
 
Table 4. Annual Costs of Health Adaptation to Climate Change. Worldwide 2000-2030 
(US$ Million, 2000). 
Cost/Scenario  Unmitigated  Stabilization at 750ppm  Stabilization at 550ppm 
Malaria   3,100 to 8,800  1,900 to 5,600  1,600 to 4,500 
Diarrhea  2,731 to 9,010  1,983 to 6,814  1,706 to 6,024 
Malnutrition   62 to 166  81 to 216  54 to 150 
All Costs  5,900 to 18,000  4,000 to 12,600  3,300 to 10,700 
 
Table 5. Additional Annual Costs of Health Adaptation in Alternative Climate Change 
Scenarios per Geographical World Region 2000-2030 (Million US$, 2000). 
REGION  Climate Scenario 
  S550  S750  UE  S550  S750  UE 
Diarrhea  Malaria 
 Developing countries    
Africa  633-1,334  756-1,646  954-2,026 
1,283-3,718  1,567-
4,595  2,508-7,222 
Americas (Central/South)  22-372  22-442  22-582  23-65  29-76  43-121 
Eastern Mediterranean  87-713  87-765  131-1,122  230-626  284-772  434-1,231 
South East Asia  952-2,198  1,106-2,542 
1,428-
3,231 
0-8 
6-9  6-17 
Western Pacific (A)  0-1,109  0-1,109  185-1,664  37-98  43-120  68-188 
 Subtotal 
1,694-
5,726  1,971-6,504 
2,719-
8,625 
1,573-4,514  1,928-
5,572  3,059-8,780 Int. J. Environ. Res. Public Health 2009, 6                 
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Table 5. Cont.  
 Developed countries   
North America  0-70  0-70  0-94  0  0  0 
Europe  12-205  12-217  12-260  0  0  0 
Western Pacific (B)  0-23  0-23  0-32 
0.136-0.370  0.177-
0.494  0.265-0.741 
 Subtotal  12-298  12-310  12-385  0.253  0.335  0.503 
WORLD 
1,706-
6,024  1,983-6,814 
2,731-
9,010 
1,573-4,515  1,928-
5,573  3,059-8,781 
Source: based on cost estimates from Ebi [19]. Note: S550 implies stabilization of emissions of GHGs at 
550 ppm by 2210. S750 implies stabilization of emissions at 750 ppm by 2170 and UE implies unmitigated 
emissions. Note: See Annex 1 reporting the member states in each region. 
 
As regards diarrhoeal diseases, South East Asia and Africa are expected to face the highest costs in 
all scenarios, accounting for respectively 42% and 27% of total annual costs for health interventions in 
developing world, followed by Western Pacific with 16%. As for malaria, the majority of the costs are 
expected in Africa (82%), followed Eastern Mediterranean countries (14%). 
In terms of gains from reducing GHGs in developing countries, Table 4 shows that we can achieve 
a 25% to 35% reduction in costs for treating diarrhoeal diseases, and 37% to 49% reduction in costs 
for malaria by reducing GHGs enough to stabilize emissions at 750 ppm and 550 ppm respectively. 
Whether  or  not  this  is  justified  will  depend  of  course  on  the  costs  of  making  the  reductions  in 
emissions as well as the other benefits of those reductions. 
The second study in this context is from Van Rensburg and Blignaut [21] who have estimated the 
additional health care costs in year 2025 due to an increase in the incidence of malaria as a result of 
climate change in Southern Africa. The analysis focuses on prevention and treatment costs of malaria. 
The incidence ratio has been calculated for different scenarios (from no risk to low and medium risk, 
from low and medium risk to high risk, and increased risk for high risk areas). Projections of future 
population  are  based  on  low  population  growth  in  the  region  because  of  the  expected  impact  of 
HIV/AIDS. For cost assessment, results from Mills [22] are used and adjusted to 2000 prices using 
purchasing power parity. Total annual costs for prevention and treatment of malaria in South Africa 
are estimated around US$ 3,800 million in 2025 (2000 US$) (Table 8) (the upper-bound cost estimates 
are  reported  which  include  all  the  measures  required  for  disease  treatment  and  prevention), 
representing 3% of GDP per capita. Costs have been estimated also for Botswana and Namibia, where 
the figures are lower because of the smaller population (US$ 125 million in Botswana;  US$ 177 
million in Namibia). Namibia is expected nevertheless to face the highest cost in terms of percentage 
of GDP/capita estimated around 4.5%. These figures are more conservative but still comparable with 
the results of Ebi [19] for malaria, where the valuation focuses on a somewhat larger timeframe and on 
all the African regions. 
The  above  mentioned  figures  can  be  compared  with  the  total  expected  costs  of  malaria  if  no 
intervention was implemented [23], which was estimated in 1999 around US$ 90-270 billion without 
considering climate change impact (estimates  are based on the observed number of cases without 
interventions; Murray and Lopez [24] have estimated around 36 million lost DALY for malaria in 
1999 in sub-Saharan Africa; two estimates of DALY have been considered: the first equal to the per 
capita income, and the second valued at three times the per capita income). This cost would be much Int. J. Environ. Res. Public Health 2009, 6                 
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higher in the presence of climate change, which is expected to increase the relative risks of malaria, 
and clearly it would be well beyond the budgetary capacity of governments. 
 
5.2. Costs of Climate-Related Disease Control Programs in the Public Health Context 
 
In this section we analyse and discuss the results of some studies estimating the costs of health 
interventions outside the climate change context but focusing on climate-related diseases and therefore 
relevant  to  the  climate  change  health  discussion.  The  diseases  looked  at  are  malaria,  diarrhoea, 
malnutrition,  pneumonia  and  other  newborn  diseases.  The  studies  included  in  the  analysis  report 
estimates for macro-geographical regions and for a combined set of intervention programs.  
The first  study  analysed is  Kiszewski  et  al.  [20]  who estimated  the overall financial  resources 
needed to implement preventive and curative measures to reduce malaria by at least 50% by 2010 and 
75% by 2015 in the most affected malaria-endemic countries (in Africa, Asia and Middle East, and 
South America), according to the recommendations stated by the World Health Assembly in 2005. The 
study reports the additional financial needs to cope with these targets, together with a comparison with 
the national governmental resources currently available for malaria control. The estimated resources 
have been calculated by gathering data from a set of widely recommended interventions. These include 
(i) prices of selected products for prevention, diagnosis and treatment of malaria, including the costs of 
distribution,  (ii)  costs  of  vector  control  and  personal  protection  (insecticidal  nets,  spraying),  (iii) 
control of epidemics, (iv) costs of preventive treatment in pregnancy; (v) management of severe cases 
and costs of rapid diagnostic tests, (vi) costs of strengthening the health care sector (train personnel 
and equipment, transport facilities and logistics improvement), (vii) communication and information 
costs,  (viii)  cost  of  prevention,  including  monitoring,  surveillance  and  evaluation  services.  Cost 
estimates in this study include therefore the full range of costs. 
The  study  integrates  cost  valuation  methodologies  with  epidemiological  estimates  about  the 
proportion of people exposed to malaria (using climatic modelling and clinical evidence of incidence) 
and projections of population growth rates (unit costs have been calculated in each country for the 
baseline year. For preventive measures, unit costs are multiplied by the total population living in areas 
at risk. For reactive measures, unit costs are multiplied by the incidence of disease in those areas. 
Future changes in demand and production have not been considered in this analysis, nor have the 
associated effects on future prices). 
Results  show  that  the  total  financial  resources  needed  from  2006  to  2015  to  implement  the 
recommended measures (in Africa, Asia, Middle East and South America) amount to US$ 38 to US$ 
46 billion (on average US$ 3.8 to 4.6 billion per year). Among the different cost categories, the vector 
control costs are estimated to be the highest. The average annual costs (2006-2015) are expected to be 
around  US$  1.7−2.2 billion for Africa, around  US$  1.9−4.6 billion for South  East  Asia, Western 
Pacific and Eastern Mediterranean, and finally US$ 212−235 million for Central and South America 
(Table 6). 
These figures are similar to the costs for health adaptation estimated by Ebi [19] (although the two 
do not measure exactly the same things). In Table 5 addressing the costs of additional cases of malaria 
in 2030 is estimated at between US$ 3 to 8.8 billion in the absence of any program to reduce GHGs 
(Table 5, last column). Thus the bottom end of the figures from Ebi are similar to the bottom end of the 
costs of reducing malaria by 75 percent in 2015, but the Ebi estimates are more nearly double the Int. J. Environ. Res. Public Health 2009, 6                 
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Kiszewski [20] figures at the top end of the range. Indeed, a telling feature of the costs of adaptation is 
their wide range. 
 
Table  6. Annual Costs of Health Interventions  to Reduce Malaria 2006-2015 (Million 
US$, 2006). 
REGION  Annual Costs 
Africa  1,707-2,186 
Americas (Central/South)  212-235 
South East Asia, Western Pacific and Eastern Mediterranean  1,903-4,638 
Total  3,823-4,638 
Source: based on cost estimates from Kiszewski et al. [20]. 
They refer to a 50% reduction by 2010 and a 75% reduction by 2015.  
 
If we compare total costs of these interventions with the national resources available for malaria 
control  we find that only  4.6 percent  of the  estimated annual  financial resources  required can be 
covered by national resources in the African countries, and only 9.2 percent in the countries of Asia, 
Oceania and Americas,  showing a financial  gap between domestic funding and  funding needs  on 
annual basis of 90-95 percent. This suggests that governments are unable to fund programs at a level 
high enough to meet the malaria targets or to treat the additional cases resulting from climate change. 
The results of Kiszewski et al. [20] can also be compared with the estimates for malaria treatment 
and prevention provided by Epstein and Mills [23]. According to this study, the overall additional 
health care expenditure required in Sub-Saharan Africa to achieve 40 percent population coverage for 
preventive measures and 50 percent coverage for treatment measures (according to the MDGs 2007) 
range from US$ 0.65 to 1.4 billion per year for prevention and from US$ 0.6 billion to 1.1 billion per 
year for treatment. The annual costs rise to US$ 1.4-3.2 billion for prevention, and US$ 1.4-2.5 billion 
for treatment, if we want to achieve the MDGs targets for 2015 of 70% prevention and treatment 
coverage. These figures are higher than those estimated by Kiszewski [20] for Africa (who estimate a 
range  from  US$  1.7  to  2.2  billion  for  both  prevention  and  treatment  of  malaria  to  ensure  80% 
coverage). They are, however, of a similar magnitude to the estimates provided by Ebi [19] under the 
unmitigated scenario for Africa regions (US$ 2.6-7.2 billion).  
Another relevant study for malaria is that of Morel et al. [25] who estimated the costs of selected 
malaria control programs in the context of the Millennium Development Goals. Analysis is focused on 
two sub-Saharan African regions, particularly vulnerable to malaria: Southern and Eastern Africa (with 
high child mortality and very high adult mortality for all causes) and Western Africa (with high child 
and high adult mortality). 
Various prevention and treatment measures and combinations of them on a 10 year timeframe are 
evaluated under different assumption of population coverage. Preventive interventions include vector 
control  programs  like  insecticide  treatment  of  bed  nets,  indoor  residual  spraying  and  intermittent 
treatment of pregnant women (aiming at reducing neonatal mortality). Treatment measures include 
distribution  of  several  drugs,  and  combination  treatments,  while  hospital  admissions  are  not 
considered. Interventions have been evaluated at 50%, 80% and 95% coverage. Population at risk is 
calculated taking into account the proportion of person living in malaria endemic areas. Results show Int. J. Environ. Res. Public Health 2009, 6                 
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that, for 95% population coverage, annual costs are equal to US$ 468 million for Western Africa and 
US$ 442 million for Southern and Eastern Africa (based on year 2000 estimation), for a combination 
of  measures  including  indoor  residual  spraying,  impregnated  bed  nets,  case  management  based 
combination therapy and intermittent presumptive treatment in pregnancy. These figures are 45 to 70 
percent  lower  than  those  provided  by  Epstein  and  Mills  [23]  and  Kiszewski  et  al.  [20],  as  some 
relevant  costs  are  not  included  in  the  analysis,  like  treatment  of  severe  and  complicated  malaria, 
training  for  staff  and  community,  communication  costs,  monitoring,  evaluation  and  operational 
research and finally all the fixed costs related to strengthening the existing infrastructures.  
A more extensive study estimating health care programs costs is Stenberg et al. [26] who estimated 
the additional resources to implement a set of measures to reduce child mortality and morbidity by 
two-thirds  by  2015  in  75  countries  in  the  developing  world,  according  to  the  Fourth  Millennium 
Development Goal. The selected countries show high mortality among children, accounting for 94 
percent of total number of deaths registered worldwide among children less than five years old. The 
causes under analysis were malnutrition, diarrhea, malaria, pneumonia and newborn causes of death in 
children. Estimates include the full range of costs including, among others, costs for immunization, 
malaria treatment and prevention, insecticide treated bed nets, diarrhea and dysentery management, 
nutrition intervention, case management of neonatal infections, and finally program costs for support 
activities (to strengthen the health system‟s capacity to provide appropriate interventions). Findings 
suggest total additional resources of US$ 52.4 billion in the period 2006-2015, resulting in additional 
annual costs of US$ 2.2 billion estimated in 2006, and US$ 7.8 billion in 2015 (estimates are based on 
the  expected  number  of  births  by  country  and  year  by  2015;  the  epidemiological  model  assumes 
constant risks up to 2015. We should note that the risk of mortality and morbidity are expected to rise 
as  a  result  of  climate  change,  and  this  is  a  main  difference  with  the  study  of  Ebi  [19]).  This  is 
equivalent to an increase in per-capita health expenditure of US$ 0.47 in 2006 and of US$ 1.46 in 
2015. The average incremental cost per child less than five years old who is treated is estimated to be 
US$ 12.31 in 2015. The suggested interventions would require an increase in total health expenditure 
in the 75 countries of around 8 percent on average and in government health expenditure of 26 percent 
over 2002 levels. Low and middle-income countries with weak health care systems would experience 
substantial difficulties to collect sufficient domestic funding to cope with MDG goals. 
Hutton  and  Haller  [27]  estimated  the  costs  of  water  and  sanitation  improvement  programs  in 
developed and developing countries. They used five different intervention scenarios to be implemented 
from year 2000 to year 2015. The health benefits are related to a decrease in water-borne diseases, 
mainly infectious diarrhea (cholera, salmonellosis, shigellosis, and other intestinal infections). Costs 
included in the analysis regard increased access of water supply and sanitation for people without 
access,  involving  investments  and  maintenance  costs.  Investment  costs  include  planning  and 
supervision, hardware, construction and house revision, protection of water sources and educational 
campaigns. Maintenance costs include operating materials, maintenance of the hardware, regulation 
and control of water supply, water treatment and distribution. These costs are essentially related to 
structural interventions outside the public health (known also as environmental health interventions), 
while the other studies mentioned above focus instead on non-structural public health measures (like 
curative  treatments  and  prevention  based  on  distribution  of  medicines  and  other  measures  like 
impregnated bed nets). Int. J. Environ. Res. Public Health 2009, 6                 
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Total annual costs of these interventions (in developing and developed countries) range from US$ 
1,782 million  in  the first  scenario to a huge  US$  136,514 million  in  the fifth  scenario. The  first 
scenario involves improvement in water accessibility only, while the second scenario involves both 
water and sanitation accessibility improvement, requiring therefore much larger financial resources 
(equal to US$ 11,303 million). Investments on sanitation are indeed considerably more expensive. In 
scenario three it is expected that the entire population has access to water and sanitation services, 
which doubles the costs of implementation (equal to US$ 22,612 million). Scenario four requires only 
a low increase in financial resources as it includes the availability of disinfected water at the point of 
use (US$ 24,648 million). 
 
Table 7. Annual Costs for Water and Sanitation Programs 2000-2015 and Expected Cases 
Avoided (Million US$, 2000). 
REGION 
Annual Costs by Intervention 
Halving 
proportion 
people without 
access to 
improved 
water 
Halving 
proportion of 
people without 
access to 
improved water 
and sanitation 
Access for 
all to 
improved 
water and 
sanitation 
Access for all 
to improved 
water and 
sanitation, 
with water 
disinfected 
Access for all 
to regulated 
piped water 
and sewage 
connection at 
home 
 Developing countries 
Africa  490  2,021  4,043  4,360  24,729 
Americas 
(Central/South)  171  788  1,577  1,937  14,085 
Eastern 
Mediterranean  57  263  526  633  7,329 
South East Asia  403  4,094  8,190  8,762  47,238 
Western Pacific (A)  565  3,621  7,243  7,686  32,767 
Subtotal  1,686  10,787  21,579  23,378  126,148 
Percent of cases 
avoided  3%  10%  17%  54%  70% 
 Developed countries 
North America  0  0  1  1  2 
Europe  77  369  738  965  9,464 
Western Pacific (B)  19  147  294  304  900 
 Subtotal  96  516  1,033  1,270  10,366 
Percent of cases 
avoided  1%  3%  6%  36%  49% 
WORLD  1,782  11,303  22,612  24,648  136,514 
Source: based on cost estimates from Hutton and Haller [27]. 
 
The  high  costs  for  the  fifth  scenario  (US$  136,414  million)  is  explained  by  the  substantial 
investments and corresponding maintenance costs necessary to guarantee access for all, in order to 
regulated piped water supply and sewage connection in the houses. These figures are much higher than 
the corresponding annual costs for non-structural interventions for disease control and prevention in Int. J. Environ. Res. Public Health 2009, 6                 
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public health but the water and sanitation programs do attain a number of other objectives as well. In 
terms of health they attain a 60-70 percent reduction in the incidence of disease.  
Table 7 reports the annual costs for the five intervention scenarios by geographical macro-regions. 
As expected, the large majority of the costs occur in developing countries, which account for around 
95 percent of total costs. Except for the first scenario, the highest share of costs (around 35 percent of 
the total) is  expected in South Eastern Asia regions (Indonesia, Sri Lanka, Thailand, Bangladesh, 
India,  Maldives,  Nepal,  Bhutan,  etc.),  followed  by  Western  Pacific  regions  (China,  Mongolia, 
Malaysia, Philippines, Korea, Viet Nam, and Cambodia) with 32 percent and Africa regions with 18 
percent of total costs. The number of cases avoided by water and sanitation programs range from 3 
percent decrease in the first scenario to 70% decrease in the last scenario. 
The  last  study  analyzed  in  this  group  is  the  one  of  Meddings  et  al.  [28]  in  the  context  of 
environmental health interventions. The study estimates costs of a program for latrine construction and 
renovation  in  Kabul  (Afganistan),  implemented  by  the  International  Committee  of  the  Red  Cross 
(ICRC) in 2006. The program allows to reduce diarrhoreal diseases. Annual costs have been estimated 
from  US$  503,948  to  979,301  (1999  US$).  This  study  is  not  fully  comparable  with  the  above 
mentioned studies as it focuses on interventions to be implemented just in one city. It has nevertheless 
been  included  in  the  review  as  it  provides  interesting  insights  for  the  cost-effectiveness  analysis 
reported in the next section. The above mentioned studies and cost assessment are synthesized in Table 
8. 
 
Table 8. Studies about the Costs of Health Intervention Programs Relevant to Climate Change. 
Study 
 
 
Coverage   Annual costs of health 
interventions in 
developing countries 
(Million US$ ) 
Cost per Case or 
Per Death Avoided 
(US$ ) 
Comments/Intervention 
Costs of health adaptation to climate change 
Ebi (2008) [19]  Malaria, diarrhea, 
malnutrition.  
(US$ 2000) 
3,100-8,800 (malaria) 
2,700-9,000 (diarrhea) 
62-166 (malnutrition) 
 
– 
Intervention program from 2000 
to 2030. Prevention and 
treatment measures. Different 
scenarios for climate 
investigated. Worldwide. 
Van Rensburg 
and Blignaut 
(2002) [21] 
Malaria.   3,800 (US$ 2000)    
– 
Intervention program from 2000 
to 2025. Prevention and 
treatment measures to achieve 
95% coverage. Different malaria 
risk scenarios. South Africa. 
Costs of climate-related disease control programs in the public health context 
Kiszewski et al 
(2007) [20] 
Malaria  3,823-4,638 (US$ 2006)   257-296 per case 
avoided (US$ 2006) 
Estimate is based on 
S. America data 
only. 
Intervention program 2006-2015 
to achieve 80% coverage and 
75% reduction in cases by 2015. 
Treatment/prevention and 
support activities programs. 
Africa, Asia and Middle East, 
South America. Int. J. Environ. Res. Public Health 2009, 6                 
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Epstein and 
Mills (2005) 
[23] 
Malaria  (US$ 2005) 
70% coverage by 2015: 
1,400-2,500 (treatment) 
1,450-3,200 (prevention) 
40%-50% coverage by 
2010: 
600-1,100 (treatment) 
650-1,400 (prevention) 
 
– 
Interventions in Sub Saharan 
Africa to achieve the 
Millennium Development Goals 
(MDGs): 
40% coverage for prevention 
and 50% for treatment by 2010. 
70% coverage for treatment and 
prevention by 2015.  
Morel et al 
(2005) [25] 
 
 
Malaria  468 (US$ 2000) (Western 
Africa) 
442 (US$ 2000) (Southern 
and Eastern Africa) 
 
– 
Intervention program for 10 
years. Combined therapy of 
preventive and treatment 
measures. Sub-Saharan Africa. 
Stenberg et al. 
(2007) [26] 
Malnutrition, 
diarrhea, malaria, 
pneumonia and 
newborn diseases. 
2,200-7,800 (US$ 2006)  314-630 per death 
avoided (US$ 2006) 
Intervention program 2006-2015 
to reduce child mortality and 
morbidity by 2/3 by 2015 
(MDGs). Prevention and 
treatment. All costs included. 75 
developing countries. 
Hutton and 
Haler (2004) 
[27] 
Diarrhea (cholera, 
salmonellosis, 
shigellosis, other 
intestinal 
infections).  
1,782-136,514 (US$ 
2000) 
11.5-36.7 per case 
avoided (US$ 2000). 
Structural intervention program 
for water and sanitation 2000-
2015. Different scenarios of 
increased access. Worldwide. 
Meddings et al 
(2004) [28] 
Diarrhea  0.5-1 (US$ 1999)  1,804-4,086 per 
child death avoided 
(US$ 1999) 
Structural interventions: latrine 
construction and rehabilitation 
program in Kabul (Afganistan). 
 
6. Cost Effectiveness of Health Protection Programs 
 
In this section we use the cost estimates from the above-mentioned studies to compute a simple 
index  of  cost-effectiveness  for  different  intervention  programs  and  health  endpoints.  We  use  two 
indicators, the cost per death or per case avoided, depending on the available data and the intervention 
targets and objectives. Only health benefits are incorporated in the index, while potential non-health 
benefits are excluded from the analysis. 
Results are reported in the fourth column of Table 8. The following conclusions can be drawn from 
these figures. The cost per case avoided of malaria in Kiszweski et al. [20] has been computed only for 
South America, for which we found available data. This cost is around US$ 260-300. It is a matter of 
judgment whether or not this is justified. One can expect a similar cost for treating cases resulting from 
climate change. 
The cost per case avoided in water and sanitation programs has been based on the data of Hutton 
and Haler [27]. More details of the costs avoided in that study are provided in Table 9, which relate to 
interventions in improved water supply and sanitation. The range of US$ 12 to US$ 37 is much lower 
than that of Kiszewski et al. [20], suggesting that programs based on improving water and sanitation 
(structural interventions outside the public health), even if requiring very high initial investments, are 
more cost effective than those involving curative treatments and prevention based on non-structural 
interventions in public health (water and sanitation programs, being structural interventions affecting Int. J. Environ. Res. Public Health 2009, 6                 
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different sectors, would provide also considerable non-health benefits in terms of time savings for 
water collection, more efficient water resources management, property value rise, increased leisure 
activities, benefits to agriculture and industry for improved water supply, and also some development 
benefits like income-generating technologies for water and sanitation access; their cost-effectiveness 
would therefore be probably even higher if all the benefits are taken into account). This is explained by 
the higher number of cases of illness avoided in the former compared to the second. 
Finally, we include the cost per death avoided estimated by Meddings et al. [28] which is much 
higher than the cost per case avoided in Hutton and Haler [27]. This can be explained by a number of 
reasons. First, the two measures are not fully comparable as they are based on different units (number 
of deaths and number of cases), which can explain part of the difference. Second, only reductions in 
child deaths are considered in Meddings et al. [28], while the other age groups are not counted in the 
cost-effectiveness ratio.  Finally, only reductions of deaths over one  year are calculated, while the 
benefits  of  the  program  would  last  for  a  number  of  years.  This  study  has  been  included  in  the 
discussion as it suggests how it is difficult to compare cost-effectiveness among health programs and 
that the results have to be interpreted with caution. For comparing costs and cost-effectiveness among 
regions  and  interventions,  it  is  essential  that  the  studies  are  fully  comparable  in  terms  of  spatial 
analysis (aggregation of geographical regions), temporal analysis and intervention types. 
 
Table 9. Annual Cost per Case of Diarrhea Avoided with Water and Sanitation Programs 
2000-2015 (US$, 2000). 
Annual Cost per Case Avoided by Intervention Scenario (US$ , 2000) 
Halving 
proportion 
people without 
access to 
improved 
water 
Halving 
proportion of 
people without 
access to 
improved water 
and sanitation 
Access for 
all to 
improved 
water and 
sanitation 
Access for all to 
improved water 
and sanitation, 
with water 
disinfected 
Access for all to 
regulated piped 
water and sewage 
connection at 
home 
11.52  20.71  25.04  8.61  36.72 
Source: based on cost estimates from Hutton and Haller [27]. 
 
The analysis is completed with a critical review of the existing studies about the cost-effectiveness 
of  single  health  interventions  in  developing  countries  (Table  10)  (see  also  [29,30]).  The  health 
outcomes under analysis are diarrhoeal diseases and malaria. For diarrhea, the interventions considered 
are immunization programs, vitamin A supplementation and breastfeeding promotion. For malaria, 
both  prevention  and  treatment  measures  are  discussed.  Prevention  includes  vaccination,  bed  nets 
impregnation,  vitamin  A  supplementation  and  prevention  in  pregnancy.  Treatment  includes  early 
diagnosis and prompt intervention with drugs.  
Results vary according to the intervention type and the country of origin. Cost effectiveness for 
immunization programs of diarrhea varies from US$ 226 to 887 (US$ 1999) per death avoided, while 
breastfeeding promotion ranges from US$ 115 to 919 per death avoided. These results confirm that Int. J. Environ. Res. Public Health 2009, 6                 
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non structural health interventions are less cost-effective compared to structural environmental health 
interventions like water and sanitation programs [27].  
As  regards  prevention  of  malaria,  cost  per  death  avoided  is  around  US$  305  (US$  1999)  for 
vaccination, it ranges from US$ 227 to 858 for bed net impregnation measures, from US$ 73 to 414 for 
vitamin A supplementation and from US$ 81 to 950 for prevention in pregnancy. Treatment measures 
of malaria show a cost per death avoided of US$ 271-1,355 for early diagnosis and prompt treatment.  
These  results  are  comparable  with  the  cost  per  death  avoided  we  estimated  using  data  from 
Kiszewsky [20] and Stenberg [26]. It must be said, however, that these latter evaluated a combination 
of different measures, while the above mentioned studies focus on single specific interventions, and 
the resulting costs per death avoided cannot be simply summed up to get an overall cost effectiveness 
ratio. A set of combined measures is in fact more cost effective than a single measure as it provides a 
higher reduction in the number of deaths and cases of disease. Of course one should choose the most 
effective measures first but it is hard to argue that a life is not worth at least that much anywhere in the 
world.  
 
Table  10.  Studies  about  the  Cost-Effectiveness  of  Health  intervention  Programs  in 
Developing Countries. 
Study 
 
 
Coverage   Cost per Death (DA) or Case 
Avoided (CA) (US$ ) 
Comments/Intervention 
Martines et al. 
(1993) [31] 
Diarrhea  226 (US$ 1999) (DA)  Immunization program. Indonesia and 
Ghana 
Shepard 
(1986) [32] 
Diarrhea  887 (US$ 1999) (DA)  Immunization program. Côte d‟Ivoire. 
USAID 
Micronutrient 
program 
(2004) [33] 
Diarrhea  236 (US$ 1999) (DA)  Standard child health intervention. 
Vitamin A supplementation. Ghana, 
Nepal, Zambia. 
Horton (1996) 
[34] 
Diarrhea  (US$ 1999) (DA) 
115-625 (Brazil) 
919 (Honduras) 
174-216 (Mexico) 
Breastfeeding promotion. Brazil, 
Honduras, Mexico. 
Martines et al. 
(1993) [31] 
Cholera  (US$ 1999) 
273 (CA) 
 
Routine cholera immunization. 
Bangladesh. 
Graves et al. 
(1998) [35] 
Malaria   (US$ 1999) (DA) 
305 (vaccine) 
858 (net impregnation)  
Malaria prevention: vaccination and 
insecticide impregnation of bed nets. 
Gambia. 
Picard et al. 
(1993) [36] 
Malaria  (US$ 1999) (DA) 
227-410 (net impregnation) 
683 (net impregnation/ 
chemoprophylaxis) 
Malaria prevention: insecticide 
impregnation of bed nets and 
chemoprophylaxis. Gambia. Int. J. Environ. Res. Public Health 2009, 6                 
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Aikins et al. 
(1998) [37] 
Malaria  537 (US$ 1999) (DA) 
 
Malaria prevention: bed net 
impregnation. Gambia. 
Loevinsohn 
(1997) [38] 
Malaria  73-279 (US$ 1999) (DA)  Malaria prevention: vitamin A 
supplementation. Philippine. 
Fiedler (2000) 
[39] 
Malaria  302-414 (US$ 199) (DA)  Malaria prevention: vitamin A 
supplementation. Nepal. 
Schulz et al. 
(1995) [40] 
Malaria  81-950 (US$ 1995) (DA)  Malaria prevention in pregnancy: 
antenatal treatment and 
chemoprophylaxis. Malawi. 
Akhavan et al. 
(1999) [41] 
Malaria  271-1,355 (US$ 1995) (DA)  Malaria treatment: early diagnosis and 
prompt treatment. Brazil. 
 
7. Conclusions and Recommendations 
 
In this paper we have looked at the costs of adapting to climate change from a health perspective 
and  we  have  computed  a  simple  cost-effectiveness  index  for  alternative  programs  based  on  the 
estimated total costs resulting from the literature. The analysis is completed with a critical review of 
the existing studies about the cost-effectiveness of different health interventions. 
There is a broad consensus that climate change will increase the costs arising from diseases such as 
malaria and diarrhea  and, furthermore, that the increases  will be largest  in  the developing  world. 
Estimates  of  the  costs  of  adaptation  measure  the  additional  cases  and  the  costs  of  treating  those 
additional  cases.  They  may  also  include  some  estimates  of  more  preventive  actions.  One  of  the 
problems in this area is a lack of any studies that measure these costs systematically and report the data 
in detail. The detailed study of Ebi [19] concludes that additional annual costs will be around US$ 3-8 
billion for malaria and US$ 3-9 billion for diarrhea worldwide. These figures are for 2030 under the 
assumption of no mitigation. Under the most optimistic stabilization scenario the costs could come 
down by as much as 40-50 percent. In the case of Africa, the additional costs in 2030 are estimated at 
US$ 2.5-7 billion for malaria and US$ 1-2 billion for diarrhea. The second study analyzed in the 
climate change context shows that additional annual costs would be around 3,800 million US$ in 2025 
in South Africa alone.  
Although these estimates refer to 2025 and 2030, which may seem a long time away, the additional 
cases are already evident and climate change is increasing the relative risk of these and other diseases 
right now. The implications are quite serious in terms of the goals of reducing deaths from malaria and 
other causes of infant and child mortality (Goals 4, 5 and 6). Estimates of expenditures made in respect 
of attaining these goals indicate expenditures for malaria alone of 2 billion US$ per annum in Africa 
(based Kiszewski et al. [20]; others indicate somewhat higher figures). If the relative risk is raised as a 
result  of  climate  change  this  sum  will  not  be  sufficient.  And  in  any  case  the  amounts  currently 
available to address these problems are only around 5 percent of the required budget. So not only are 
the MDGs in danger of not being met on grounds of insufficient funds, they are also in danger of not 
being met and of progress being reversed as a result of climate change. 
The case for making these expenditures is strong, on economic as well as on moral grounds. One of 
the studies cited estimates the costs to people who contract malaria and who are not treated at US$ 90-Int. J. Environ. Res. Public Health 2009, 6                 
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270 billion in sub-Saharan Africa in 1999 [23]. This is almost two orders of magnitude greater than the 
annual costs of health programs for treatment and prevention (Epstein and Mills [23] estimate that if 
action is taken to treat cases and introduce other health interventions the avoided costs would range 
from US$ 87 to 267 billion. The costs without interventions are thus much higher and the expenditures 
on intervention amply justified. Furthermore if we consider that the rise in global temperatures is 
expected  to  increase  the  relative  risks  of  malaria  incidence,  the  impacts  will  be  all  the  greater). 
Furthermore we find that the cost per death avoided through disease control programs focusing on 
combined health interventions is of the order of US$ 300-600. On moral grounds most of us would 
find it unacceptable to believe that a life is not worth that much in even the poorest country. 
The paper provides finally a critical analysis of the reported studies coming from the public health 
literature showing a number of relevant points, which should be considered in future research. The 
magnitude of the costs of health interventions for reducing climate-sensitive diseases (not related to 
climate change) is comparable to the costs of health adaptation under climate change but the latter 
have  a  much  wider  range.  Hence  more  work  is  needed  to  narrow  the  estimates  of  the  costs  of 
adaptation. 
The studies make it difficult to identify which interventions are the most cost effective in targeting 
diseases  related  to  climate  change.  A  more  consistent  approach  to  further  work  in  reporting  cost 
effectiveness indicators would help us make more informed judgments. One problem is the use of 
different metrics (cost per case or per death avoided). Another is how to consider programs with 
multiple  benefits.  As  regards  malaria,  for  example,  the  measures  relate  to  disease  prevention  and 
treatment and they provide mainly health benefits. For diarrhoea, instead, structural intervention can be 
implemented which provide also considerable non-health benefits. These should be also taken into 
account when computing the cost-effectiveness ratio. 
In spite of this we note that the costs per life saved in the case of diarrhoea are considerably lower 
than those in the case of malaria. That would suggest at least starting out targeting diarrhoea cases. 
Furthermore,  within  that  group  the  costs  of  improved  water  and  sanitation,  while  requiring  huge 
investments to meet the MDGs, result in costs per case avoided that are fairly low. Given that these 
same interventions have multiple benefits, not all of which have been accounted for would suggests 
that non-health structural interventions may be more cost effective but further research is needed to 
confirm this. 
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Annex 1. WHO Regions. 
Region  Description  Member States 
Africa  Developing  countries 
with high mortality 
Algeria, Angola, Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Comoros, 
Equatorial Guinea, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, 
Madagascar, Mali, Mauritania, Mauritius, Niger, Nigeria, San Tome and 
Principe, Senegal, Seychelles, Sierra Leone, Togo 
Botswana, Burundi, Central African Republic, Congo, Cote d‟Ivoire, Democratic 
Republic of the Congo, Eritrea, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, 
Namibia, Rwanda, South Africa, Swaziland, Uganda, United Republic of 
Tanzania, Zambia, Zimbabwe 
North 
America 
Developed countries 
with very low 
mortality 
Canada, Cuba, United States of America 
Central and 
South 
America 
Developing  countries 
with low mortality  
Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Brazil, Chile, 
Colombia, Costa Rica, Dominica, Dominican Republic, El Salvador, Grenada, 
Guyana, Honduras, Jamaica, Mexico, Panama, Paraguay, Saint Kitts and Nevis, 
Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, 
Uruguay, Venezuela (Bolivarian Republic of) 
  Developing  countries 
with high mortality  
Bolivia, Ecuador, Guatemala, Haiti, Nicaragua, Peru 
South East 
Asia 
Developing  countries 
with low mortality 
Indonesia, Sri Lanka, Thailand 
 
  Developing  countries 
with high mortality  
Bangladesh, Bhutan, Democratic People‟s Republic of Korea, India, Maldives, 
Myanmar, Nepal, Timor-Leste 
Europe  Developed countries 
with very low mortality 
Andorra, Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, 
France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, 
Monaco, Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, 
Switzerland, United Kingdom 
  Developed countries 
with low mortality 
Albania, Armenia, Azerbaijan, Bosnia and Herzegovina, Bulgaria, Georgia, 
Kyrgyzstan, Poland, Romania, Serbia and Montenegro, Slovakia, Tajikistan, The 
former Yugoslav Republic of Macedonia, Turkey, Turkmenistan, Uzbekistan 
  Developed countries 
with low child and high 
adult mortality 
Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, 
Russian Federation, Ukraine 
Eastern 
Mediterranean 
Developing  countries 
with low mortality  
Bahrain, Iran (Islamic Republic of), Jordan, Kuwait, Lebanon, Libyan Arab 
Jamahiriya, Oman, Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United 
Arab Emirates 
  Developing  countries 
with high mortality  
Afghanistan, Djibouti, Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, Yemen 
Western 
Pacific (A) 
Developed countries 
with very low mortality 
Australia, Brunei Darussalam, Japan, New Zealand, Singapore 
Western 
Pacific (B) 
Developing  countries 
with low mortality  
Cambodia, China, Cook Islands, Fiji, Kiribati, Lao People‟s Democratic 
Republic, Malaysia, Marshall Islands, Micronesia (Federated States of), 
Mongolia, Nauru, Niue, Palau, Papua New Guinea, Philippines, Republic of 
Korea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu, Viet Nam 
Source: adapted from WHO 2002 [42]. 